PDS Biotechnology Corporation

PDSB · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$38-$43-$41-$17
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$7$8$5$4
Change in WC-$6-$0$4$0
Other Non-Cash$1$2$5$0
Operating Cash Flow-$35-$34-$26-$12
Investing Activities
PP&E Inv.-$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$0$0$0$0
Financing Activities
Debt Repay.-$3-$0$25$0
Stock Issued$23$16$10$49
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$1$0-$1$0
Financing Cash Flow$20$16$34$49
Forex Effect$0$0$0$0
Net Chg. in Cash-$15-$17$9$36
Supplemental Information
Beg. Cash$57$74$65$29
End Cash$42$57$74$65
Free Cash Flow-$35-$34-$26-$12
PDS Biotechnology Corporation (PDSB) Financial Statements & Key Stats | AlphaPilot